Dr. Sharad Ghamande
Claim this profileAugusta University Medical Center
Expert in Cancer
Expert in Breast Cancer
68 reported clinical trials
145 drugs studied
About Sharad Ghamande
Education:
- Earned MD from Bombay University, India, in 1990.
- Completed Residency in Obstetrics and Gynecology at Boston Medical Center, Boston University, in 1997.
- Completed Fellowship in Gynecologic Oncology at Roswell Park Cancer Institute, Buffalo, New York, in 2000.
Experience:
- Holds the position of Associate Professor and Executive Vice Chair at Augusta University.
- Serves as the Director for Gynecological Oncology and the William Brooks Chair in Obstetrics and Gynecology at Augusta University.
- Actively involved in clinical and research interests, focusing on ovarian cancer, radical cancer surgery, and chemotherapy trials.
- Plays a key role in mentoring GYN Oncology Fellows and increasing patient accrual to NCORP.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 positive
HER2 negative
ER negative
Affiliated Hospitals
Clinical Trials Sharad Ghamande is currently running
Ipatasertib + Megestrol Acetate
for Endometrial Cancer
This trial is testing if combining two drugs, ipatasertib and megestrol acetate, is more effective than using megestrol acetate alone for treating women with endometrial cancer that has returned or spread. Ipatasertib blocks enzymes needed for cancer cell growth, while megestrol acetate reduces and blocks estrogen, which some cancer cells need to grow.
Recruiting1 award Phase 1 & 2
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
More about Sharad Ghamande
Clinical Trial Related1 year of experience running clinical trials · Led 68 trials as a Principal Investigator · 32 Active Clinical TrialsTreatments Sharad Ghamande has experience with
- Carboplatin
- Nivolumab
- Atezolizumab
- Pembrolizumab
- Paclitaxel
- Ipilimumab
Breakdown of trials Sharad Ghamande has run
Cancer
Breast Cancer
Ovarian Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sharad Ghamande specialize in?
Sharad Ghamande focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Sharad Ghamande currently recruiting for clinical trials?
Yes, Sharad Ghamande is currently recruiting for 31 clinical trials in Augusta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Sharad Ghamande has studied deeply?
Yes, Sharad Ghamande has studied treatments such as Carboplatin, Nivolumab, Atezolizumab.
What is the best way to schedule an appointment with Sharad Ghamande?
Apply for one of the trials that Sharad Ghamande is conducting.
What is the office address of Sharad Ghamande?
The office of Sharad Ghamande is located at: Augusta University Medical Center, Augusta, Georgia 30912 United States. This is the address for their practice at the Augusta University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.